HemostOD appoints an International Scientific Advisory Board

HemostOD is proud to present the profiles of our distinguished scientific advisors.

We are thrilled to announce the establishment of a Scientific Advisory Board at HemostOD, marking a pivotal step in our mission to revolutionize the development of platelets for transfusion. As we work towards pioneering innovative solutions in transfusion medicine, we recognize the critical importance of collaboration with world-renowned experts to guide our research and development efforts.

Our Scientific Advisory Board brings together a diverse group of leading scientists and clinicians from across the globe, each offering unique expertise in areas ranging from hematology, cell therapy, and biotechnology to clinical transfusion practices, regulatory affairs, and commercialization strategies. Their invaluable guidance will accelerate our progress as we develop cutting-edge, safe, and scalable platelet products for patients in need.

Meet Our Advisory Board: - Prof. Terry B. Gernsheimer, MD (Fred Hutch Cancer Center, Seattle): Clinical expert in hematology, with a focus on transfusion medicine and platelet disorders - Prof. Florence Salmon, PhD (Basel): Regulatory, cell therapy CMC expert - Prof. Andrew L. Frelinger, PhD (Harvard Medical School): A leader in platelet biology - Prof. Philippe Renaud, PhD (EPFL, Lausanne): Microfluidics expert with a focus on biomedical applications

We are honored to work with such a distinguished group of advisors and are confident that their collective expertise will be instrumental in advancing our mission to develop life-saving platelet therapies.